The Role of Non-Invasive Methods in Evaluating Liver Fibrosis of Patients With Non-Alcoholic Steatohepatitis

Imaging in Medicine- United Kingdom

doi 10.14303/imaging-medicine.1000123

Full Text

Abstract

Available in

Date

Authors

Publisher

OMICS Publishing Group

Related search

Meta-Analysis: Pioglitazone Improves Liver Histology and Fibrosis in Patients With Non-Alcoholic Steatohepatitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2011English

Non-Invasive Diagnosis of Fibrosis in Non-Alcoholic Fatty Liver Disease

Journal of Clinical and Experimental Hepatology
Hepatology
2012English

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Sorafenib Prevents Liver Fibrosis in a Non-Alcoholic Steatohepatitis (NASH) Rodent Model

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2015English

How Do Non-Invasive Fibrosis Scoring Systems Compare With Transient Elastography in the Diagnosis of Fibrosis in Patients With Non Alcoholic Fatty Liver Disease

Gut
Gastroenterology
2011English

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis

PLoS ONE
Multidisciplinary
2010English

The Roles of Gap Junctional Intercellular Communication in Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

1. Fatty Liver and Non-Alcoholic Steatohepatitis

Internal Medicine
Internal MedicineMedicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy